Compared with the M group, SC TD displayed the strongest amelioration of pathological changes, significantly reduced the size of islet cells (p < 0.001), decreased the apoptosis of islet cells (p < 0.001), and enhanced insulin secretion (p < 0.05). The gene discussed is INS; the disease is thanatophoric dysplasia.